Amarin Corp Plc (AMRN)

[Biobillionair]

To add to SR, Amarin has specific patents related to non active ingredients in capsule preserving the active form. The "generic" document DEMANDS the same inactive ingredients thus validating the Patent until 2030. So it's more like a 17 yr NCE designation if capsule patent holds. Also note the separation between Lovaza's alpha-tocopherol and Amarins just "tocopherol". The USP also changed Icosapent Ethyl to Icosapent Ethyl CAPSULE.

Good luck defeating a patent that both the USP and FDA support.